EFPIA - NEWSLETTER

EFPIA Newsletter 15 March 2018

Immune diseases and machine learning feature in new IMI Call for proposals

Today, the Innovative Medicines Initiative (IMI) is launching a new EUR 82 million Call for proposals focusing on immune diseases, imaging, machine learning, and digital clinical trials. Read more

You can access IMI2 – Call 14 page here.

Deadline for submitting short proposals: 14 June 2018.

Events

21 MAR 2018

12022018 FEAM annual lecture on “Biomedical and health research: developing a vision... Brussels, Belgium

The annual lecture will bring together policy-makers and high-level representatives from across different biomedical...

Learn more →

16 APR 2018

2018 China/EU Pharmaceutical Industry Forum Basel, Switzerland

An event jointly organised by EFPIA and CPIA

Learn more →

16 APR 2018

12 February 2018 ‘Real-World Evidence in Medicine Development’: an online introductory... Online learning

An online introductory course by GetReal

Learn more →

10 MAY 2018

13122017 European Conference on Rare Diseases and Orphan Products Messe Wien Congress Center, Vienna, Austria

The largest multi-stakeholder gathering in Europe for the rare disease community

Learn more →

What we are reading

EU Manifesto on Influenza Vaccination 12 March 2018 (EUfightingflu)

What Pharma Firms Should Be Doing Now To Prepare For A ‘No Deal’ Brexit 14 March 2018 (Pink Sheet)

NHS faces ‘serious challenges’ from Brexit, warns new report 14 March 2018 (EurActiv)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶